Skip to main content
Article thumbnail
Location of Repository

Nutrigenomics, individualism and public health.

By Ruth Chadwick


Issues arising in connection with genes and nutrition policy include both nutrigenomics and nutrigenetics. Nutrigenomics considers the relationship between specifc nutrients or diet and gene expression and, it is envisaged, will facilitate prevention of diet-related common diseases. Nutrigenetics is concerned with the effects of individual genetic variation (single nucleotide polymorphisms) on response to diet, and in the longer term may lead to personalised dietary recommendations. It is important also to consider the surrounding context of other issues such as novel and functional foods in so far as they are related to genetic modification. Ethical issues fall into a number of categories: (1) why nutrigenomics? Will it have important public health benefits? (2) questions about research, e.g. concerning the acquisition of information about individual genetic variation; (3) questions about who has access to this information, and its possible misuse; (4) the applications of this information in terms of public health policy, and the negotiation of the potential tension between the interests of the individual in relation to, for example, prevention of conditions such as obesity and allergy; (5) the appropriate ethical approach to the issues, e.g. the moral difference, if any, between therapy and enhancement in relation to individualised diets; whether the 'technological fix' is always appropriate, especially in the wider context of the purported lack of public confidence in science, which has special resonance in the sphere of nutrition

Year: 2004
OAI identifier:
Provided by: Lancaster E-Prints

Suggested articles


  1. (1997). Advisory Committee on Genetic Testing doi
  2. (1998). Cunningham-Burley S & Amos A doi
  3. (2003). Food Portions may Explain the ‘French Paradox’ of Rich Foods and a Thin Population (posted 28/08/03).
  4. (2003). Functional Foods. doi
  5. (2003). Genetic associations in large versus small studies: an empirical assessment. doi
  6. (1998). Genetic screening. doi
  7. (2003). Genomics – a global public good?
  8. Hedgecoe A (2002) Commercial exploitation of the human genome. doi
  9. (2001). Human Genetic Databases: Challenges and Opportunities. London: The Stationery Office; available at ldselect/ldsctech/57/5701.htm Human Genetics Commission
  10. Human Genome Organisation Ethics Committee (2000) Statement on Benefit-sharing. doi
  11. (2001). Informed consent in genetic research. doi
  12. (1963). Lectures on Ethics. doi
  13. (2003). Nutrigenomics: goals and strategies. doi
  14. (1998). Organisation Ethics Committee doi
  15. Organisation Ethics Committee (2002) Statement on Human Genomic Databases. doi
  16. (2001). Organization doi
  17. (2003). Phenylketonuria.
  18. (2001). Solidarity and equity: new ethical frameworks for genetic databases.
  19. (1994). The ethics of screening: is screening-itis an incurable disease? doi
  20. (1968). The Principles and Practice of Screening for Disease. Public Health Papers no. 34.
  21. (2001). Your Genetic Destiny: Know Your Genes, Secure Your Health, Save Your Life. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.